Inspire Q3 2022 Earnings Report
Key Takeaways
Inspire Medical Systems reported strong third-quarter results with a 77% increase in revenue compared to the previous year, driven by increased utilization at existing sites and expansion of implanting centers and sales territories. The company is raising its full-year 2022 revenue guidance to $384 million to $388 million.
Generated revenue of $109.2 million, a 77% increase year-over-year.
Achieved a gross margin of 81.9%.
Activated 59 new centers in the U.S., bringing the total to 844.
Created 18 new U.S. sales territories, bringing the total to 209.
Inspire
Inspire
Inspire Revenue by Geographic Location
Forward Guidance
Inspire is increasing its full year 2022 revenue guidance to between $384 million to $388 million and is maintaining its full year 2022 gross margin guidance of 83% to 85%.
Revenue & Expenses
Visualization of income flow from segment revenue to net income